56 filings
Page 3 of 3
8-K
9pyp4dcgo46 mmo
19 Jan 21
Results of Operations and Financial Condition
4:05pm
8-K
b2ttm
10 Nov 20
Fulcrum Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
7:05am
8-K
ldnhbj5p3ilu2
11 Aug 20
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
7:15am
8-K
u5x53 pgt
23 Jul 20
Entry into a Material Definitive Agreement
4:30pm
8-K
dx4otf5xlz
26 Jun 20
Other Events
4:45pm
8-K
axhawqctri3jb
11 Jun 20
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
lo8wck9tztj0rmg78
10 Jun 20
Entry into a Material Definitive Agreement
4:15pm
8-K
93zun42wxa8e1iqs
13 May 20
Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results
7:10am
8-K
pzhb6pk0kza qzm
2 Apr 20
Other Events
8:20am
8-K
ov3ixd o8
5 Mar 20
Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results
7:12am
8-K
0rgo thfkcrg
6 Jan 20
Fulcrum Therapeutics Appoints Katina Dorton to its Board of Directors
7:48am
8-K
4stezez
30 Dec 19
Entry into a Material Definitive Agreement
7:34am
8-K
8tru3 uvz
14 Nov 19
Fulcrum Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
7:10am
8-K
hnry3hic
4 Oct 19
Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
6:08am
8-K
j89lugov60l00kzbhc1
26 Aug 19
Results of Operations and Financial Condition
7:10am
8-K
e8k7cphak8
22 Jul 19
Amendments to Articles of Incorporation or Bylaws
4:10pm